Detalles de la búsqueda
1.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection;
52(3): 1191-1194, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771466
2.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica;
2024 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572549
3.
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies.
Ann Hematol;
103(6): 2123-2131, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436671
4.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection;
52(3): 1125-1141, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388854
5.
Impact of familiarity with the format of the exam on performance in the OSCE of undergraduate medical students - an interventional study.
BMC Med Educ;
24(1): 179, 2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395807
6.
A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in ß-thalassemic mice.
Blood Adv;
8(8): 1898-1907, 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241484
7.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol;
42(1): e3240, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050405
8.
[Recent findings in myelodysplastic syndrome]. / Neueste Erkenntnisse zum myelodysplastischen Syndrom.
Dtsch Med Wochenschr;
148(22): 1431-1436, 2023 11.
Artículo
en Alemán
| MEDLINE | ID: mdl-37918427
9.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Int J Antimicrob Agents;
62(4): 106952, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582478
10.
Concerns on perioperative anaemia management in the FIT trial.
Lancet Haematol;
10(7): e485, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37407135
11.
High concordance of clone detection between peripheral blood and bone marrow by targeted next-generation sequencing-A pilot study in patients with MDS.
Br J Haematol;
202(3): e16-e19, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263977
12.
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.
EClinicalMedicine;
58: 101939, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37041967
13.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol;
16(1): 32, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005697
14.
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Blood Adv;
7(11): 2645-2655, 2023 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058479
15.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol;
14: 1125030, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36911708
16.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol;
14: 20406207231154706, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36923264
17.
Tissue iron distribution in patients with anemia of inflammation: Results of a pilot study.
Am J Hematol;
98(6): 890-899, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880875
18.
Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency.
Haematologica;
108(1): 135-149, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35796011
19.
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.
Hemasphere;
6(11): e789, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36310756
20.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood;
140(26): 2773-2787, 2022 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126318